ALEX CHENG: Open Payments
NPI 1275987836 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 101 payments from 16 companies in 2025. Trend: 2023 $709 · 2024 $810 · 2025 $1,498
Food & beverage: $1,498
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $230 |
| Otsuka America Pharmaceutical, Inc. | 13 | $229 |
| Neurocrine BioSciences, Inc. | 17 | $191 |
| Teva Pharmaceuticals USA, Inc. | 12 | $180 |
| Alkermes, Inc. | 7 | $120 |
| E.R. Squibb & Sons, L.L.C. | 6 | $93 |
| Vanda Pharmaceuticals Inc. | 5 | $92 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $60 |
| Neos Therapeutics, LP | 3 | $58 |
Products named: REXULTI, VRAYLAR, INGREZZA, AUSTEDO XR, COBENFY, ARISTADA, Auvelity, UZEDY.
Industry payments across NY — which companies pay providers there.
